|
ABOUT COMPANY
SCYNEXIS, Inc., a biotechnology company, offers therapies for the treatment of yeast infections in the United States. The company is headquartered in Jersey City, New Jersey.
|
EARNINGS
Gross Profit (TTM): 121000
Market Capitalization: 151125000
Operating Margin (TTM): -4.288
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 0.553
Revenue (TTM): 12566000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: -1
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -2.601
Dividend Date: 2020-07-17
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -38041000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|